This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Lab of Functional and Biomedical Nanomaterials, College of Materials Science and Engineering, Qingdao University of Science and Technology, Qingdao, China
E-mail: kchen@qust.edu.cn
; Fax: +86 532 84022509
Dalton Trans., 2013,42, 1752-1759
DOI:
10.1039/C2DT31783D
Received
04 Aug 2012,
Accepted
29 Oct 2012
First published online
29 Oct 2012
As bimodal magnetic-fluorescent imaging agents, the preparation of ZnS:Tb,Gd and ZnS:Er,Yb,Gd nanoparticles via a facile homogeneous precipitation method is reported. The results show that these nanoparticles are almost spherical in shape with a diameter of 100–200 nm approximately and a major phase of wurtzite-structured ZnS. The products can successfully label the human hepatocellular carcinoma (HepG2) cells and present low toxicity even at concentrations up to 5 mg mL−1. Additionally, for the ZnS:Er,Yb,Gd nanoparticles calcinated above 950 °C, NIR-to-visible up-conversion fluorescence were obtained, which is believed to be superior to traditional ZnS-based bioimaging agents with down conversion. In MRI studies, they reveal a longitudinal relaxivity rate (r1) of 39.46 mM−1 s−1 and 57.8 mM−1 s−1, respectively, which are much larger than the conventional Gd-DTPA and currently reported Gd-base nanoparticles, suggesting great potential as MRI agents.
Fetching data from CrossRef. This may take some time to load.